Several long-term research participants – Helmut and Josephine Weigold, Deirdre Casey and Rodney Bayley – have played crucial roles in advancing understanding of how age-related macular degeneration (AMD) progresses.

Important discoveries, landmark treatment approvals and new funding have made the past year one of the most significant yet for age-related macular degeneration research.

Mirugen, a biotech spin-out from CERA, has received new investment to bring a new treatment for retinitis pigmentosa closer to clinical trial.

An innovative project is exploring whether exosomes – tiny particles made by our own cells – could become powerful vehicles for delivering future treatments for macular diseases.

When most people think about organ and tissue donation, they picture one person receiving a generous gift that saves or transforms their life.